SLS

SELLAS Life Sciences Group Inc

May 15 • 04:00PM ET

7.08

-0.34 -4.58 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: XNCR RCUS FATE KURA ADCT

| Held by: XBI IWM VTI IWO VXF VFMO VTWO IWC PTH LABU

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.23	Insider Own	1.27%	Shs Outstand	186.03M	Perf Week	41.32%
Market Cap	1.32B	Forward P/E	-	EPS next Y	-0.15	Insider Trans	2.76%	Shs Float	183.68M	Perf Month	43.61%
Enterprise Value	1.21B	PEG	-	EPS next Q	-0.05	Inst Own	28.06%	Short Float	31.11%	Perf Quarter	97.21%
Income	-29.46M	P/S	-	EPS this Y	16.00%	Inst Trans	3.04%	Short Ratio	8.36	Perf Half Y	375.17%
Sales	0.00M	P/B	11.95	EPS next Y	28.57%	ROA	-39.50%	Short Interest	57.15M	Perf YTD	87.80%
Book/sh	0.59	P/C	12.29	EPS next 5Y	50.68%	ROE	-43.58%	52W High	7.80 -9.23%	Perf Year	342.50%
Cash/sh	0.58	P/FCF	-	EPS past 3/5Y	51.28% 34.92%	ROIC	-27.35%	52W Low	1.39 409.35%	Perf 3Y	331.71%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	12.78% 7.47%	Perf 5Y	-13.13%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	41.60%	Oper. Margin	-	ATR (14)	0.49	Perf 10Y	-99.98%
Dividend Ex-Date	Mar 24, 2011	Quick Ratio	17.22	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	71.90	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	17.22	EPS Q/Q	26.44%	SMA20	35.26%	Beta	2.36	Target Price	10.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	39.79%	Rel Volume	1.24	Prev Close	7.42
Employees	13	LT Debt/Eq	0.00	Earnings	May 12 AMC	SMA200	123.82%	Avg Volume	6.84M	Price	7.08
IPO	Mar 12, 2008	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.67% -	Trades		Volume	8,466,997	Change	-4.58%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)